THYSOL Group: Innovating Health and Performance through Medical Taping and Fascia Therapy. THYSOL Group is a leading medical device company dedicated to delivering cutting-edge products and services in the realm of medical taping. Through a robust network of partners across global markets, we ensure unwavering quality and continuous innovation. Our company is built upon three core pillars: CureTape: Our premier brand, renowned for high-quality medical tapes, BeautyTape and Crosslinq Patches. VetkinTape: Expertly crafted for veterinary applications, enhancing animal care. FASCIQ: Offering an all-encompassing approach to fascia treatment with state-of-the-art tools and methodologies. With a presence in over 80+ countries, we collaborate closely with distributors to make our superior tapes and medical devices accessible locally. Our dedicated technical team is constantly innovating, refining our products to better meet the needs of our customers.
Looking for a particular THYSOL Group employee's phone or email?
THYSOL Group Questions
The THYSOL Group annual revenue was $7 million in 2026.
Peter Thissen is the Managing Director of THYSOL Group.
6 people are employed at THYSOL Group.
THYSOL Group is based in Enschede, Overijssel.
The NAICS codes for THYSOL Group are [42345, 423, 42, 4234].
The SIC codes for THYSOL Group are [50, 504].
Top THYSOL Group Employees
-
Peter Thissen
Managing Director at THYSOL Group
Amsterdam, NH, NL11 -
Gert Olthoff
Co Owner at THYSOL Group
Enschede, NL1 -
1
Related Companies
